Fischer Medical Ventures Ltd (FISCHER) share price, results, shareholding

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	20.79	10.12	39.66	11.75	49.17	23.44	86.31	101.10	97.54	81.92
Expenses	0.00	18.28	10.33	39.16	11.38	46.66	19.45	70.09	79.53	101.31	70.67
Operating Profit	0.00	2.51	-0.21	0.50	0.37	2.51	3.99	16.22	21.57	-3.77	11.25
OPM %		12.07%	-2.08%	1.26%	3.15%	5.10%	17.02%	18.79%	21.34%	-3.87%	13.73%
Other Income	0.00	0.47	0.69	0.05	0.38	0.15	7.47	2.48	1.09	0.77	1.48
Interest	0.00	0.05	0.13	0.05	0.07	0.23	0.66	0.92	0.64	3.66	3.54
Depreciation	0.00	0.18	0.28	0.29	0.56	0.51	0.77	0.51	0.77	0.93	1.36
Profit before tax	0.00	2.75	0.07	0.21	0.12	1.92	10.03	17.27	21.25	-7.59	7.83
Tax %		6.18%	271.43%	-38.10%	350.00%	26.04%	51.55%	19.46%	9.18%	64.03%	51.60%
Net Profit	0.00	2.59	-0.12	0.29	-0.29	1.31	4.86	13.90	19.23	-12.44	3.79
EPS in Rs	0.00	0.05	-0.00	0.01	-0.01	0.02	0.07	0.21	0.30	-0.19	0.06

	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0	21	111	308	367
Expenses	0	19	107	265	322
Operating Profit	0	2	3	43	45
OPM %	11%	9%	3.0%	14%	12%
Other Income	0	0	1	12	6
Interest	0	0	0	6	9
Depreciation	0	0	2	3	4
Profit before tax	0	2	3	47	39
Tax %		13%	37%	33%
Net Profit	-0	2	1	31	24
EPS in Rs	-0.24	0.03	0.02	0.49	0.38
Dividend Payout %	0%	0%	22%	1%

	10 Years	5 Years	3 Years	TTM	1 Year	Last Year
Compounded Sales Growth	%	%	1097%	196%
Compounded Profit Growth	%	%	831%	286%
Stock Price CAGR	69%	21%	71%		-69%
Return on Equity	%	%	6%			9%

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.17	54	64	65
Reserves	-0	28	274	320
Borrowings	1	2	85	107
Other Liabilities	0	4	34	179
Total Liabilities	0	86	457	671
Fixed Assets	0	15	24	32
CWIP	0	0	1	3
Investments	0	1	7	118
Other Assets	0	70	425	519
Total Assets	0	86	457	671

	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-7	-86	-101
Cash from Investing Activity	-29	-125	-5
Cash from Financing Activity	37	315	14
Net Cash Flow	1	103	-92
Free Cash Flow	-8	-91	6
CFO/OP	-392%	-2,555%	-194%

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	345	398	251	342
Inventory Days		99	36	58
Days Payable		48	82	466
Cash Conversion Cycle	345	449	205	-67
Working Capital Days	324	498	42	159
ROCE %		5%	1%	11%

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Aug 2026
Promoters	0.00%	0.00%	74.91%	74.91%	74.91%	62.82%	61.80%	61.80%	61.80%	62.15%	62.15%	63.09%
FIIs	0.00%	5.07%	5.07%	5.07%	5.07%	5.23%	5.55%	5.57%	4.85%	4.97%	5.48%	5.57%
DIIs	0.00%	1.68%	1.68%	1.68%	1.68%	1.44%	1.42%	1.42%	1.36%	1.38%	1.35%	1.26%
Public	99.99%	93.24%	18.33%	18.33%	18.32%	30.51%	31.23%	31.22%	31.99%	31.51%	31.01%	30.09%
No. of Shareholders	9,038	8,976	9,285	9,502	9,688	10,180	10,058	13,054	22,920	23,269	23,950	23,951

Fundamentals

Market Cap₹ 2,355 Cr.

Current Price₹ 33.7

Stock P/E96.2

Book Value₹ 5.88

ROCE11.4 %

ROE8.91 %

Dividend Yield0.15 %

Face Value₹ 1.00

Compounded Sales Growth (TTM)196%

Compounded Profit Growth (TTM)286%

Consolidated figures.

Ownership

Promoter holding63.09% (+1.29 in a year)

Computed by MarketFriction from the consolidated statements. Returns use average balances.

Not enough history to build valuation bands (needs two years of profits and prices).

Period	FISCHER	Nifty 50	Difference
1 week	-2.2%	-2.8%	+0.5 pts
1 month	-9.0%	-6.8%	-2.2 pts
3 months	-14.8%	-7.6%	-7.2 pts
6 months	-17.4%	+0.4%	-17.8 pts
1 year	-71.1%	-9.9%	-61.2 pts
3 years	+400.9%	+14.2%	+386.7 pts
5 years	+174.7%	+27.9%	+146.8 pts

2 mutual fund schemes hold about ₹0 Cr. Over three months 0 bought more and 1 sold (share counts, price move removed).

Fund	Weight	Est. Cr	3m shares
Bandhan BSE Healthcare Index Fund	0.05%	0	-6%
Motilal Oswal BSE 1000 Index Fund	0.00%	0

Red flags

No red flags in the latest statements and filings.

Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026

Sales ₹82 Cr +249.5% vs Jun 2025. Net profit ₹4 Cr -22.0%.

Activity

Compare

Company	Mcap (Cr)	P/E	ROCE
Poly Medicure Ltd	16,671	52.1	12.5 %
Molbio Diagnostics Ltd	14,470	66.6	18.0 %
Tarsons Products Ltd	1,754	148	4.59 %
Q-Line Biotech Ltd	1,569	27.8	22.5 %
Laxmi Dental Ltd	1,058	30.4	15.0 %
Hemant Surgical Industries Ltd	869	51.3	18.9 %
Vasa Denticity Ltd	754	62.3	7.54 %
OSEL Devices Ltd	691	23.6	24.4 %
Prevest Denpro Ltd	462	20.5	24.9 %
QMS Medical Allied Services Ltd	419	39.0	12.9 %
Nureca Ltd	349	80.4	3.30 %
Aprameya Engineering Ltd	200	39.7	12.6 %
Avience Biomedicals Ltd	198	22.7	27.0 %
Earkart Limited	179	36.3	17.5 %
Vaidya Sane Ayurved Laboratories Ltd	176	19.6	15.1 %

No bulk or block deals on record.

Ex-date	Action	Factor
2026-09-22	Dividend - Re 0.05 Per Share
2025-09-22	Dividend - Rs 0.005 Per Share
2025-09-12	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share	0.1000

Date	Type	What it says
2026-10-01	Shareholder meeting	Voting results.
2026-09-29	Shareholder meeting	Proceedings of Annual General Meeting held on September 29, 2026
2026-09-28	General Updates	General Updates
2026-09-26	Corrigendum	Corrigendum to Annual Report FY 2025-26
2026-09-25	Board meeting outcome	Outcome of Board Meeting held on September 24, 2026.
2026-09-17	Updates	Presentation of Investor/Analyst meeting.
2026-09-16	Updates	Chairmans Letter to Shareholders.
2026-09-07	Concall / analyst meet	Presentation
2026-09-04	Concall / analyst meet	Schedule of meet
2026-09-03	Board meeting outcome	Outcome of Board Meeting held on September 03, 2026.
2026-09-03	General Updates	Outcome of Board meeting held on 03/09/2026
2026-09-03	Record Date	Record date for the purpose of Dividend is 22-Sep-2026.
2026-08-28	Press Release	A press release dated August 28, 2026, titled "Time Medical International Ventures Launches Next-Generation CLARION 64/128-Slice AI-Driven CT System a...
2026-08-24	Press Release	A press release dated August 24, 2026, titled "Catanduanes Integrated Digital Healthcare Project Awarded to Time Medical Philippines Advancing the ...
2026-08-17	General Updates	On the allotment of Equity shares pursuant to conversion of warrants
2026-08-15	Resignation	Resignation of Director/KMP/SMP
2026-08-15	Resignation	Resignation of Director/KMP/SMP
2026-08-14	General Updates	On allotment of Equity shares pursuant to conversion of warrants
2026-08-14	Director change	Change in Director(s) of the company.
2026-08-14	Board meeting outcome	Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-13	Monitoring Agency Report	Monitoring Agency Report for the quarter ended 30th June 2026
2026-08-13	General Updates	About allotment of equity shares pursuant to conversion of warrants
2026-08-12	General Updates	Allotment of equity shares pursuant to conversion of warrants
2026-08-11	General Updates	Allotment of Equity shares pursuant to conversion of warrants
2026-07-31	Press Release	A press release dated July 31, 2026, titled "Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Venture...

Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.

No short selling reported to NSE in our files.

Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.

High low price variation greater than 150perc in previous 12 monthsHigh low price variation greater than 200perc in previous 365 DaysScrip PE is greater than 50 (4 trailing quarters)